Event: BIOMEDevice Panel Session
Tuesday, September 21, 2021 | 2:15 PM to 3:00 PM ET
Panel Session: My CDMO Has Been Acquired – Now What? featuring Alira Health’s Carlo Stimamiglio
2020 was a record year for merger and acquisitions (M&A) for contract development and manufacturing organizations (CDMO), and deals have continually increased in 2021. This panel of MedTech experts will discuss how the pandemic recovery is driving increased M&A, how long it will last, and what it means for employees, supply chain partners, and customers. This panel will take a look at how medical device companies identify which CDMOs are best positioned to be successful in a merger or acquisition situation, including insights gained from how they manage customers through the process, and why technology should be a core consideration when choosing a CDMO partner.
• How M&A activity affects medical device manufacturing and supply chain sourcing options
• Ways to protect your R&D and design intellectual property during an acquisition
• How new technology allows contract manufacturers to produce more complex products faster, consistently, and efficiently
• Questions to ask before agreeing to a multi-year manufacturing commitment
David Dykeman (Moderator)
Co-Chair, Global Life Sciences & Medical Technology Group
Greenberg Traurig, LLP
Vice President, Industry Marketing, Medical Device & Life Sciences
Chief Quality Officer
Who is attending?